Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hematologic Neoplasms × Exercise Test × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Obesity 1 Lymphoma, Non-Hodgkin 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Heart Defects, Congenital 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Carcinoma, Transitional Cell 1

Interventions

Cyclophosphamide 7 venetoclax 5 fludarabine 5 Specimen Handling 5 trametinib 4 Tacrolimus 4 Mycophenolic Acid 4 fludarabine phosphate 3 Thiotepa 3 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Azacitidine 3 talquetamab 2 pembrolizumab 2 dabrafenib 2 Whole-Body Irradiation 2 Surveys and Questionnaires 2 Standard of Care 2 Sirolimus 2 Peripheral Blood Stem Cell Transplantation 2 Methylprednisolone 2 Mesna 2 Health Promotion 2 Filgrastim 2 Cytarabine 2 Busulfan 2 Biopsy 2 ruxolitinib 1 quizartinib 1 plerixafor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡